This is an indirect indication that the birds fed zinc from Availa-Zn experienced less intestinal inflammation from the wheat-rye diet
In a separate study involving 190 patients receiving 52 weeks of treatment, remission rates were 36.8%, 45.6%, and 52.0% for the 5, 10, and 15 mg tirzepatide groups, respectively, compared to 18.2% in the placebo group (Nevola et al., 2023)
Of the 3,791 studies we investigated, 715 were active 2 and 69% of those involved either Diabetes or Obesity
Zepbound, which activates both GLP-1 and GIP receptors, may offer enhanced appetite control and greater weight loss benefits for some individuals
Low-dose GLP-1 combined with personalized biomarker monitoring and feedback